MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression

Lei Sun1, Guangqing Bian2, ZhaoJun Meng1

  • 1Department of Ophthalmology, The Fourth Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, China.

Plos One
|May 12, 2015
PubMed

Insights

MicroRNA-144 (miR-144) acts as a tumor suppressor in uveal melanoma. Restoring miR-144 inhibits cancer cell growth and metastasis by targeting c-Met, suggesting it as a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • Emerging evidence links miRNAs to cancer development and progression.
  • The specific role of miR-144 in uveal melanoma metastasis was previously unclear.

Purpose of the Study:

  • To investigate the function of miR-144 in uveal melanoma.
  • To determine the molecular mechanisms underlying miR-144's action in this cancer.
  • To evaluate miR-144 as a potential therapeutic target for uveal melanoma.

Main Methods:

  • Quantitative analysis of miR-144 expression in uveal melanoma cells and tissues.
  • In vitro functional assays including cell growth and invasion assays.
  • Luciferase reporter assays to validate miR-144 binding sites on c-Met mRNA.
  • Western blot analysis to assess c-Met protein levels.

Main Results:

  • miR-144 expression was significantly downregulated in uveal melanoma.
  • Overexpression of miR-144 suppressed uveal melanoma cell proliferation and invasion.
  • miR-144 directly targets the 3' UTR of c-Met mRNA, inhibiting its translation.
  • Restoration of miR-144 reduced c-Met protein expression and its downstream effects.

Conclusions:

  • miR-144 functions as a tumor suppressor in uveal melanoma.
  • The miR-144/c-Met pathway plays a critical role in uveal melanoma progression.
  • miR-144 represents a promising therapeutic target for uveal melanoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K